Cancer is a leading cause of death worldwide and, despite new targeted therapies and
immunotherapies, many patients with advanced-stage-or high-risk cancers still die, owing to …

Chimeric antigen receptor (CAR) T‐cell therapy is a promising immunotherapy with high
acquisition costs, and it has raised concerns about affordability and sustainability in many …

Cell and gene therapies have demonstrated excellent clinical results across a range of
indications with chimeric antigen receptor (CAR)–T cell therapies among the first to reach …

Customer segmentation divides customers into groups of consumers with similar patterns or
characteristics relevant to marketing, especially with respect to target advertising. These …

The traditional paradigm for pharmaceutical manufacturing is focused primarily upon
centralized facilities that enable mass production and distribution. While this system reliably …

Background aims Decentralized, or distributed, manufacturing that takes place close to the
point of care has been a manufacturing paradigm of heightened interest within the cell …

Cellular agriculture, the manufacturing of animal-sourced foods by cell cultures, may
promote food security by providing a food source that is available, accessible, utilized, and …

Background aims Autologous cell therapy (AuCT) is an emerging therapeutic treatment that
is undergoing transformation from laboratory-to industry-scale manufacturing with recent …

Cybersecurity for the production of safe and effective biopharmaceuticals requires the
attention of multiple stakeholders, including industry, governments, and healthcare …

Cell therapies based on T cell have gathered interest over the last decades for treatment of
cancers, becoming recently the most investigated lineage for clinical trials. Although results …